Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- RMCL-CL001Independent statistical analysis of Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Robotic and Conventional Hand Therapy After Stroke: Complete Statistical AnalysisIndependent statistical analysis of Robotic and Conventional Hand Therapy After Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03020576).
- Robotic Bronchoscopy for Peripheral Pulmonary Lesions: Complete Statistical AnalysisIndependent statistical analysis of Robotic Bronchoscopy for Peripheral Pulmonary Lesions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03727425).
- Robotic Gait Rehabilitation in Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Robotic Gait Rehabilitation in Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05218187).
- Robotic-assisted Therapy to Improve Manual Dexterity in Children With Cerebral Palsy: Complete Statistical AnalysisIndependent statistical analysis of Robotic-assisted Therapy to Improve Manual Dexterity in Children With Cerebral Palsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ROBUSTIndependent statistical analysis of Multicenter Prospective Trial of Office-based Carpal Tunnel Release With Ultrasound Guidance (ROBUST): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ROCKIndependent statistical analysis of A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma: primary…
- ROCKETIndependent statistical analysis of A Phase 2 Randomized, Open-Label Study of RRx-001 vs Regorafenib in Subjects With Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ROCKET-ASTROIndependent statistical analysis of A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Rocket-BPSIndependent statistical analysis of Evaluation of The Postprandial Impact of Automated Priming Bolus for Full Closed Loop Insulin Delivery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ROCKIIndependent statistical analysis of Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in Taiwan: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02616380).
- ROCSIndependent statistical analysis of Risk of Oxygen During Cardiac Surgery Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02361944).
- Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy Adults: Complete Statistical AnalysisIndependent statistical analysis of Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS): Complete Statistical AnalysisIndependent statistical analysis of Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS): primary endpoint results, effect estimate with confidence…
- Roflumilast Plus Antipsychotics Proof of Mechanism Study in Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Roflumilast Plus Antipsychotics Proof of Mechanism Study in Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02079844).
- ROIDS-DoseIndependent statistical analysis of Randomized Open Investigation Determining Steroid Dose: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04834375).
- Role of Apathy in the Effectiveness of Weight Loss Interventions: Complete Statistical AnalysisIndependent statistical analysis of Role of Apathy in the Effectiveness of Weight Loss Interventions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00548652).
- Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Role of Proinflammatory Signaling in Alcohol Craving: Complete Statistical AnalysisIndependent statistical analysis of Role of Proinflammatory Signaling in Alcohol Craving: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01631630).
- Role of Soy Supplementation in Prostate Cancer Development: Complete Statistical AnalysisIndependent statistical analysis of Role of Soy Supplementation in Prostate Cancer Development: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00255125).
- Role of the Gut Microbiome on Lean Mass and Physical Function in Older Adults: Complete Statistical AnalysisIndependent statistical analysis of Role of the Gut Microbiome on Lean Mass and Physical Function in Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Role of Vacuum Assisted Closure (VAC) Device in Postoperative Management of Pelvic and Acetabular Fractures: Complete Statistical AnalysisIndependent statistical analysis of Role of Vacuum Assisted Closure (VAC) Device in Postoperative Management of Pelvic and Acetabular Fractures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Rollover Study of BMS-354825 in Patients With CML and Ph+ALL: Complete Statistical AnalysisIndependent statistical analysis of Rollover Study of BMS-354825 in Patients With CML and Ph+ALL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01030718).
- Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Esophageal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Esophageal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Lumacaftor in Combination With Ivacaftor: Complete Statistical AnalysisIndependent statistical analysis of Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Lumacaftor in Combination With Ivacaftor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ROLoIndependent statistical analysis of Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ROMEO (Rosuvastatin in Metabolic syndrOme): Complete Statistical AnalysisIndependent statistical analysis of ROMEO (Rosuvastatin in Metabolic syndrOme): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00395486).
- Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine: Complete Statistical AnalysisIndependent statistical analysis of Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Romidepsin in Treating Patients With Steroid-Refractory Graft-versus-Host Disease: Complete Statistical AnalysisIndependent statistical analysis of Romidepsin in Treating Patients With Steroid-Refractory Graft-versus-Host Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02203578).
- Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS): Complete Statistical AnalysisIndependent statistical analysis of Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Ropidoxuridine and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases: Complete Statistical AnalysisIndependent statistical analysis of Ropidoxuridine and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- RopivacaineIndependent statistical analysis of Interscalene Nerve Blocks With Ropivacaine Alone, With Dexamethasone, Plus Systemic Dexamethasone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Ropivacaine Block Alone or With Perineural or Systemic Dexamethasone for Pain in Shoulder Surgery: Complete Statistical AnalysisIndependent statistical analysis of Ropivacaine Block Alone or With Perineural or Systemic Dexamethasone for Pain in Shoulder Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ROSEIndependent statistical analysis of A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ROSEIndependent statistical analysis of Reevaluation Of Systemic Early Neuromuscular Blockade: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02509078).
- Rosiglitazone Effect on Mitochondria and Lipoatrophy: Complete Statistical AnalysisIndependent statistical analysis of Rosiglitazone Effect on Mitochondria and Lipoatrophy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00367744).
- ROTATEQ Reexamination Study (V260-037): Complete Statistical AnalysisIndependent statistical analysis of ROTATEQ Reexamination Study (V260-037): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01074242).
- Rotator Cuff Pathway: Complete Statistical AnalysisIndependent statistical analysis of Rotator Cuff Pathway: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03717753).
- Rotator Cuff Tears in Hemiplegic Shoulder: Complete Statistical AnalysisIndependent statistical analysis of Rotator Cuff Tears in Hemiplegic Shoulder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00998868).
- ROXI-VTE IIIndependent statistical analysis of A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants: primary endpoint results, effect estimate with confidence interval, sample-size…
- RPIndependent statistical analysis of REAL Parenting Alcohol and Substance Use App: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03932097).
- RPCWIndependent statistical analysis of Prevention of Alcohol-related Sexual Revictimization in College: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05257603).
- RPDIndependent statistical analysis of Reciprocating Medical Devices - a Study of a New Safety Device: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- RPS InflammaDry Detector™ to Determine MMP-9 Levels in Tears: Complete Statistical AnalysisIndependent statistical analysis of RPS InflammaDry Detector™ to Determine MMP-9 Levels in Tears: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01313351).
- RRRIndependent statistical analysis of Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation to Treat Radiation Retinopathy.: primary endpoint…
- RSLV-132Independent statistical analysis of A Study of RSLV-132 in Subjects With Primary Sjogren's Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03247686).
- RSV-OA=ADJ-020Independent statistical analysis of A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy Adults: primary endpoint results, effect estimate with confidence…
- RSVHRIndependent statistical analysis of A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery: Complete Statistical AnalysisIndependent statistical analysis of RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- RTDIndependent statistical analysis of Obtain a Good Blood Glucose Control With the Paradigm Real Time System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…